Pyxis Oncology (PYXS) Amortizatization of Intangibles (2023 - 2025)
Pyxis Oncology's (PYXS) quarterly Amortizatization of Intangibles came in at $375000.0 in Q4 2025, down 75.54% year-on-year from $1.5 million in Q4 2024, and down 29.51% on a QoQ basis from $532000.0 in Q3 2025.
Pyxis Oncology (PYXS) Amortizatization of Intangibles (2023 - 2025) Analysis & Trends
Pyxis Oncology (PYXS) has 3 years of Amortizatization of Intangibles data on file, last reported at $375000.0 in Q4 2025.
- On a quarterly basis, Amortizatization of Intangibles fell 75.54% year-over-year to $375000.0 in Q4 2025; TTM through Dec 2025 was $3.0 million, a 51.55% decrease from a year earlier, with the FY2025 full-year figure at $3.0 million, down 51.55% from the prior year.
- Amortizatization of Intangibles for Q4 2025 stood at $375000.0, down from $532000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for PYXS reached as high as $1.7 million in Q3 2024 and fell as low as $375000.0 in Q4 2025.
- Historically, Amortizatization of Intangibles has averaged $1.2 million across 3 years, with a median of $1.3 million in 2023.
- Across the five-year window, Amortizatization of Intangibles jumped 112.19% in 2024 and slumped 75.54% in 2025, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $1.4 million in 2023, then increased by 6.38% to $1.5 million in 2024, then slumped by 75.54% to $375000.0 in 2025.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $375000.0 in Q4 2025, $532000.0 in Q3 2025, and $896000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Pyxis Oncology | 182.39 Mn | 115.53 Mn | 8.65 Mn | 375,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 375,000.00 |
| Dec 31, 2025 | 375,000.00 |
| Sep 30, 2025 | 532,000.00 |
| Sep 30, 2025 | 532,000.00 |
| Jun 30, 2025 | 896,000.00 |
| Jun 30, 2025 | 896,000.00 |
| Mar 31, 2025 | 1.16 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Sep 30, 2024 | 1.65 Mn |
| Sep 30, 2024 | 1.65 Mn |
| Jun 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | 1.29 Mn |
| Mar 31, 2024 | 1.29 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Sep 30, 2023 | 1.48 Mn |
| Sep 30, 2023 | 1.48 Mn |